Robert I. Blum
Board Member
Cytokinetics Inc (CYTK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert I. Blum
Robert I. Blum is recorded as CEO and Board Member at Cytokinetics Inc (CYTK). Cytokinetics Inc reported in an 8-K filed May 17, 2024 that Robert I. Blum was appointed Class II Directors, effective May 15, 2024. The proxy statement of Cytokinetics Inc reports total compensation of $11,881,456 for Robert I. Blum in fiscal 2025, including a base salary of $853,069. Disclosed compensation is on record for 4 fiscal years.
“The stockholders elected Robert I. Blum and Robert A. Harrington, M.D. as Class II Directors, each to serve for a three-year term and until their successors are duly elected and qualified or their earlier resignation or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-15–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cytokinetics Inc
Other people whose current roles at this company are on record from its filings.
- Robert Blum CEO
- John T. Henderson, M.D. Chairman
- Sung H. Lee CFO
- Brett Pletcher General Counsel
- Jeffrey J. Hessekiel General Counsel
- Mark A. Schlossberg General Counsel
- Mr. Schlossberg General Counsel
- Mr. Wong Chief Accounting Officer
- Robert Wong Chief Accounting Officer
- Sung Lee Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cytokinetics Inc (CYTK) | Principal Executive Officer | $853,069 | $11,881,456 |
| 2024 | Cytokinetics Inc (CYTK) | Principal Executive Officer | $825,550 | $14,368,343 |
| 2023 | Cytokinetics Inc (CYTK) | Principal Executive Officer | $790,000 | $8,751,057 |
| 2022 | Cytokinetics Inc (CYTK) | Principal Executive Officer | $742,410 | $8,547,825 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.